Code intelligence

FDA-NDA021314 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code FDA-NDA021314.

Normal code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Normal

Critical

High

Routine

100%

Low

New this month

—

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

FDA Approval: IDKIT HP ONE (CITRIC ACID ANHYDROUS AND 13C UREA) — Type 3 - New Dosage Form

Policy FDA-NDA021314 · Gastroenterology

Routine

IDKIT HP ONE (citric acid anhydrous and 13C urea) is an oral diagnostic agent approved for detecting Helicobacter pylori infection via the urea breath test. As an oral drug administered in an outpatie

View alert

Audit documentation

Building an audit file that includes FDA-NDA021314?

The Tripwire Audit Pack exports 12 months of Gastroenterology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Gastroenterology audit pack — $349One-time purchase · not a subscription